Emergent BioSolutions Cash from Financing (TTM) Trends

Emergent BioSolutions Inc (EBS)

2.00 +0.14 (+7.53%) USD | NYSE | Apr 19, 13:14

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
December 31, 2023	-535.70M
September 30, 2023	-187.30M
June 30, 2023	85.00M
March 31, 2023	541.20M
December 31, 2022	481.20M
September 30, 2022	18.10M
June 30, 2022	-216.20M
March 31, 2022	-189.30M
December 31, 2021	-141.00M
September 30, 2021	-33.30M
June 30, 2021	58.80M
March 31, 2021	67.30M
December 31, 2020	69.50M
September 30, 2020	13.90M
June 30, 2020	-92.90M
March 31, 2020	2.50M
December 31, 2019	-35.90M
September 30, 2019	807.90M
June 30, 2019	829.30M
March 31, 2019	732.40M
December 31, 2018	788.70M
September 30, 2018	-29.92M
June 30, 2018	-28.36M
March 31, 2018	-30.79M
December 31, 2017	-51.40M

Date	Value
September 30, 2017	-13.47M
June 30, 2017	-61.24M
March 31, 2017	-46.76M
December 31, 2016	-19.80M
September 30, 2016	-10.10M
June 30, 2016	37.49M
March 31, 2016	28.65M
December 31, 2015	35.39M
September 30, 2015	24.17M
June 30, 2015	21.49M
March 31, 2015	17.00M
December 31, 2014	198.87M
September 30, 2014	202.70M
June 30, 2014	202.94M
March 31, 2014	200.49M
December 31, 2013	8.612M
September 30, 2013	-3.215M
June 30, 2013	-4.233M
March 31, 2013	-2.02M
December 31, 2012	-1.765M
September 30, 2012	2.506M
June 30, 2012	17.22M
March 31, 2012	14.51M
December 31, 2011	16.66M
September 30, 2011	20.58M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-535.70M

Minimum

Dec 2023

829.30M

Maximum

Jun 2019

81.22M

Average

13.90M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks